Petra Denig

ORCID iD
https://orcid.org/0000-0002-7929-4739
  • Other IDs
  • Show details Hide details
ResearcherID: L-9865-2014

Sources:
Clarivate Analytics (2014-09-27)

Biography

Petra Denig received her PharmD from the University of Groningen. She defended her PhD thesis titled ‘Drug choice in medical practice – Rationales, routines and remedies’ in 1994. After that, she was coordinator for the international BIOMED I – Drug Education Project and supervisor on many research projects within the Rational Drug Use group at the University of Groningen. Research topics include: the evaluation and understanding of drug prescribing, and the development of tools to support rational drug use. Since 2004, Petra has been project leader of the GIANTT-project (www.giantt.nl). This GIANTT project (Groningen Initiative to Analyse Type 2 diabetes Treatment) is a regional initiative of healthcare providers and researchers focusing on diabetes care. The primary goal is to improve the quality of care delivered to patients with type 2 diabetes mellitus. GIANTT offers benchmark reports to participating general practices in the north of The Netherlands, using various performance measures (e.g. process and outcome quality indicators). Furthermore, GIANTT initiates and facilitates scientific research to assess determinants of quality of care, to evaluate initiatives for improving the quality of care, and the impact of care on patient outcomes in a routine care setting (www.giantt.nl/onderzoek.htm). At the end of 2013, Petra was appointed as Professor of Drug Utilisation Quality at the Faculty of Medical Sciences, serving the University Medical Center Groningen. Major research aim is to develop innovative strategies and insights that contribute to optimal use of medicines in practice. The focus is on chronic and complex diseases, particularly cardiovascular diseases and diabetes.